Association and correlation of different chemotherapeutic regimens and doses with onset and severity of anemia among solid cancer patients

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 10, 2011, Pages 2753-2758

  Hassan, Bassam Abdul Rasool ^a   Yusoff, Zuraidah Binti Mohd ^a   Hassali, Mohamed Azmi ^a   Othman, Saad Bin ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Anemia; Chemotherapy regimens; Doses; Solid cancers

Indexed keywords

EID: 84858174337     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. American Society of Health System Pharmacist (2010). Monograph - cisplatin. in 'American Society of Health System Pharmacit', Eds Maryland, American Society of Health System Pharmacist pp 1-5.
2. Barrett-Lee, P, Bokemeyer, C, Gascon, P, et al (2005). Management of cancer-related anemia in patients with breast or gynecologic cancer: New Insights Based on Results from the European Cancer Anemia Survey. The Oncologist, 10, 743-57.
3. Beguin Y (2005). Endogenous eryhthropoietin in the anemia of chronic disorders in 'Anemia of chronic disease', Eds Weiss G, Gordeuk VR and Hershko C. Taylor & Francis Group, New York pp 145-200.
4. Blaser L (2001). Anemia. in 'The Gale Encyclopedia of Science', Eds Mcgrath KA and Lachford SB. Farmington Hills, Gale group. Michigan pp 11-31.
5. Brown T, Olde TG (2005). Anemia. in 'The Gale Encyclopedia of Cancer2', Eds Longe JL. Detroit Gale group. Detroit pp 20-37.
6. Cazzola M (2000). Mechanisms of anaemia in patients with malignancy: implications for the clinical use of recombinant human erythropoietin. Med Oncol, 17, 11-16.
7. Christle Hospital NHS Foundation Trust (2008) 5 Fluorouracil (5FU), Epirubicin & Cyclophosphamide (FEC). Ed Christle Hospital Patient Information Service.
8. Danova M, Aglietta M, Pierelli L (2000). The use of erythropoietin alpha in programs of highdose chemotherapy. Rec Prog Med, 91, 681-9.
9. Drug Information Online (2010). Cyclophosphamide Side Effects. Ed About Drugs.Com and About Drugs.com. http://www.drugs.com/sfx/cyclophosphamide-side-effects.html
10. Glaspy J, Jadeja JS, Justice G (2001). A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy. Br J Cancer, 84, 17-23.
11. Goldrick A, Olivotto IA, Alexander CS, et al (2007). Anemia is a common but neglected complication of adjuvant chemotherapy for early breast cancer. Curr Oncol, 14, 227-33.
12. Groopman JE, Itri LM (1999). Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst, 91, 1616-634.
13. Haggerty M (1999). Anemia. in The Gale Encyclopedia of Medicine, Eds Olendorf D, Jeryan, C, Boyaden K. Farmington Hills, Gale Research, An international Thomson company. pp 19-27.
14. Hamilton S (2010). 5-FU. in Cleveland Clinic Foundation, Eds Cleveland Clinic Foundation. http://www.chemocare.com/BIO/fu.asp
15. Haut A (2007). Anemia. in "Encyclopedia of Science and Technology', Eds Weil, J, Blumel, D, Tylor, R, Geller, E, McGraw-Hill, New York pp 11-20.
16. Howland RD, Mycek MJ (2006). Anticancer Drugs, Philadelphia, Lippincott Williams & Wilkins, pp 453-484.
17. Ishmael DR, Liu H, Nordquist JA, et al (2005) Phase I trial of concurrent administration of Topotecan and Docetaxel for cancer treatment. J Appl Res, 5, 53-60.
18. Kirshner J, Hatch, M, Hennessy DD, et al (2004). Anemia in stage II and III breast cancer patients treated with adjuvant doxorubicin and cyclophosphamide chemotherapy. The Oncologist, 9, 25-32.
19. Kosmidis P, Krzakowski M. (2005). Anemia profiles in patients with lung cancer: What have we learned from the European Cancer Anaemia Survey (ECAS)? Lung Cancer, 50, 401-12.
20. Pohl G, Ludwig H. (2005). Positive effects of correction of anemia in malignant diseases. in 'Anemia of Chronic Disease', Eds Weiss G, Gordeuk, VR, Hershko C. Taylor & Francis, New York pp 31-54.
21. Rang H, Dale MM, Ritter JM, Moore PK (2003). Pharmacology, London, Churchill Livingstone, pp 694-698.
22. Rogers BB. (2009). Chemotherapy-induced Nausea and Vomiting. Supportive Care, May, 18-22.
23. Ruggiero A, Attina G, Haber M, et al (2008). Assessment of chemotherapy-induced anemia in children with cancer. Cent Eur J Med, 3, 341-5.
24. Scurr M, Judson I, Root T. (2005). Combination chemotherapy and chemotherapy principles. in 'The Royal Marsden Hospital Handbook of Cancer Chemotherapy', Eds Brighton D, Wood M. Elsevier/Churchill Livingstone, London pp 15-27.
25. Stephan P (2010). Fluorouracil - 5 FU - Adrucil - Chemotherapy for Breast Cancer. Breast Cancer. New York, About.com, a part of The New York Times Company.
26. Vizor S (2005). Lung cancer. in 'The Royal Marsden Hospital Hhandbook of Cancer XChemotherapy/ A Guide for the Multidisciplinary Team', Eds Brighton D, Wood M., Elsevier/ Churchill Livingstone, New York pp 53-62.
27. Vogelzang NJ, Breitbart W, Cella D (1997). Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. Semin Hematol, 34, 4-12.
28. Wood PA, Hrushesky WJM (1995). Cisplatin-associated anemia: an erythropoietin deficiency syndrome. J Clin Invest, 95, 1650-9.